


The Fund aims provide a monthly income of 2% over base rate whilst keeping fluctuations in the unit price to a minimum.
| Name | % Net Assets |
|---|---|
| BP | 2.8% |
| Vodafone | 1.9% |
| GlaxoSmithKline | 1.9% |
| HSBC | 1.8% |
| Royal Dutch Shell | 1.1% |
| RBS | 1.1% |
| AstraZeneca | 0.9% |
| Barclays | 0.8% |
| HBOS | 0.8% |
| Lloyds TSB | 0.6% |
| Key | % Net Assets |
|---|---|
| 2.8% | |
| 1.9% | |
| 1.9% | |
| 1.8% | |
| 91.6% |
| Date | 20-May-2024 |
|---|---|
| Bid | 11.57p |
| Offer | 12.14p |
| Currency | GBP |
| Change | 0.005p |
| % | -0.04% |
| YTD change | 11.86p |
| YTD % | n/a |
| Fund Inception | 26/01/1993 |
|---|---|
| Fund Manager | Chris Childs |
| TER | 1.74 (30-Apr-2011) |
| Minimum Investment | |
|---|---|
| Initial | £2500 |
| Additional | £500 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | -0.10 |
You are here: research